ATE430936T1 - Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome - Google Patents
Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinomeInfo
- Publication number
- ATE430936T1 ATE430936T1 AT05819706T AT05819706T ATE430936T1 AT E430936 T1 ATE430936 T1 AT E430936T1 AT 05819706 T AT05819706 T AT 05819706T AT 05819706 T AT05819706 T AT 05819706T AT E430936 T1 ATE430936 T1 AT E430936T1
- Authority
- AT
- Austria
- Prior art keywords
- cyfra
- osteopontin
- markers
- colorectal cancer
- colorectal carcinoma
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4742—Keratin; Cytokeratin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04030619 | 2004-12-23 | ||
PCT/EP2005/013867 WO2006066915A1 (en) | 2004-12-23 | 2005-12-22 | Use of cyfra 21-1 as a marker for colorectal cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE430936T1 true ATE430936T1 (de) | 2009-05-15 |
Family
ID=34927964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05819706T ATE430936T1 (de) | 2004-12-23 | 2005-12-22 | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome |
Country Status (10)
Country | Link |
---|---|
US (1) | US7731938B2 (de) |
EP (1) | EP1831695B1 (de) |
JP (1) | JP4606469B2 (de) |
CN (2) | CN101088011B (de) |
AT (1) | ATE430936T1 (de) |
CA (1) | CA2585788C (de) |
DE (1) | DE602005014386D1 (de) |
ES (1) | ES2325277T3 (de) |
HK (1) | HK1115636A1 (de) |
WO (1) | WO2006066915A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2059813A2 (de) * | 2006-06-26 | 2009-05-20 | Technion Research & Development Foundation LTD. | Verfahren und kits zur krebsdiagnose |
JP4981133B2 (ja) * | 2006-08-01 | 2012-07-18 | エフ.ホフマン−ラ ロシュ アーゲー | 肺癌用マーカーとしてのnnmtの使用 |
US20100196889A1 (en) * | 2006-11-13 | 2010-08-05 | Bankaitis-Davis Danute M | Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer |
JP5591711B2 (ja) * | 2007-12-10 | 2014-09-17 | エフ.ホフマン−ラ ロシュ アーゲー | 結腸直腸癌のためのマーカーパネル |
CN102138074B (zh) | 2008-07-03 | 2014-08-13 | 霍夫曼-拉罗奇有限公司 | 用作肺癌标记物的asc |
US9075060B2 (en) * | 2009-06-16 | 2015-07-07 | Technion Research & Development Foundation Limited | Methods for diagnosing oral or oral-pharyngeal cancer |
US20130095503A1 (en) * | 2010-01-05 | 2013-04-18 | University Of Cincinnati | Serum spla2-iia as diagnosis marker for prostate and lung cancer |
US9255142B2 (en) * | 2010-09-09 | 2016-02-09 | Beijing Cotimes Biotech Co., Ltd. | Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof |
WO2012123299A1 (en) * | 2011-03-11 | 2012-09-20 | Roche Diagnostics Gmbh | Asc as marker for chronic obstructive pulmonary disease (copd) |
US9725491B2 (en) * | 2012-04-24 | 2017-08-08 | Bogazici Universitesi | Method for antigen delivery |
KR101619122B1 (ko) | 2013-08-14 | 2016-05-10 | 연세대학교 산학협력단 | 탈메틸화 의존적 asc 발현을 촉진시켜서 대장암 종양세포의 사멸감수성을 증진시키는 항암제 병용 투여용 후보물질의 스크리닝 방법 |
JP6750140B2 (ja) * | 2014-08-22 | 2020-09-02 | アボット・ラボラトリーズAbbott Laboratories | 直腸結腸がんを早期検出するための方法 |
WO2019120527A1 (en) * | 2017-12-20 | 2019-06-27 | Michael Heneka | Novel means and methods for treating neurodegenerative diseases |
KR102293271B1 (ko) * | 2019-02-25 | 2021-08-23 | 가톨릭대학교 산학협력단 | Cyfra 21-1을 이용한 갑상선암 림프절 전이 진단 방법 |
CN113785199B (zh) * | 2019-03-01 | 2024-02-09 | 先进标志物探索公司 | 用于诊断结肠直肠癌和/或其癌前阶段的蛋白质特征 |
US20230204584A1 (en) * | 2020-03-19 | 2023-06-29 | Advanced Marker Discovery S.l. | Protein signature for screening general population for colorectal cancer and/or pre-cancerous stage thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6165740A (en) * | 1998-09-30 | 2000-12-26 | Sysmex Corporation | Method and device for flow-cytometric microorganism analysis |
US7118912B2 (en) * | 2002-08-26 | 2006-10-10 | Case Western Reserve University | Methods and compositions for categorizing patients |
US20040157278A1 (en) * | 2002-12-13 | 2004-08-12 | Bayer Corporation | Detection methods using TIMP 1 |
CN100437115C (zh) * | 2002-12-20 | 2008-11-26 | 霍夫曼-拉罗奇有限公司 | 烟酰胺n-甲基转移酶作为结肠直肠癌标志的用途 |
JP4241822B2 (ja) * | 2003-05-26 | 2009-03-18 | エフ.ホフマン−ラ ロシュ アーゲー | 結腸直腸癌に対するマーカーとしてのタンパク質maspの使用 |
-
2005
- 2005-12-22 CN CN200580044411XA patent/CN101088011B/zh not_active Expired - Fee Related
- 2005-12-22 CA CA2585788A patent/CA2585788C/en not_active Expired - Fee Related
- 2005-12-22 WO PCT/EP2005/013867 patent/WO2006066915A1/en active Application Filing
- 2005-12-22 JP JP2007543807A patent/JP4606469B2/ja not_active Expired - Fee Related
- 2005-12-22 ES ES05819706T patent/ES2325277T3/es active Active
- 2005-12-22 EP EP05819706A patent/EP1831695B1/de not_active Not-in-force
- 2005-12-22 AT AT05819706T patent/ATE430936T1/de active
- 2005-12-22 DE DE602005014386T patent/DE602005014386D1/de active Active
- 2005-12-22 CN CNA2005800445589A patent/CN101088012A/zh active Pending
-
2007
- 2007-06-19 US US11/764,913 patent/US7731938B2/en active Active
-
2008
- 2008-05-30 HK HK08106060.4A patent/HK1115636A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2006066915A1 (en) | 2006-06-29 |
CN101088011B (zh) | 2012-07-18 |
HK1115636A1 (en) | 2008-12-05 |
CN101088012A (zh) | 2007-12-12 |
ES2325277T3 (es) | 2009-08-31 |
JP2008522172A (ja) | 2008-06-26 |
CA2585788A1 (en) | 2006-06-29 |
US20080020414A1 (en) | 2008-01-24 |
EP1831695B1 (de) | 2009-05-06 |
EP1831695A1 (de) | 2007-09-12 |
CA2585788C (en) | 2013-03-05 |
CN101088011A (zh) | 2007-12-12 |
DE602005014386D1 (de) | 2009-06-18 |
US7731938B2 (en) | 2010-06-08 |
JP4606469B2 (ja) | 2011-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE430936T1 (de) | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome | |
ATE554389T1 (de) | Apex als marker für lungenkrebs | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
ATE425266T1 (de) | Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten | |
WO2009074276A3 (en) | Marker panel for colorectal cancer | |
ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
CY1122022T1 (el) | Αναπτυξη και χρηση φθοριζοντων ανιχνευτων αδεσμευτης χολερυθρινης | |
CA2701341A1 (en) | Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex | |
ATE459883T1 (de) | Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose | |
HUP0303888A2 (hu) | FKBP-nukleinsavak és -polipeptidek prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise | |
ATE513216T1 (de) | Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome | |
ATE462803T1 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
CY1112553T1 (el) | Ανοσοπροσδιορισμοι υψηλης ευαισθησιας και κιτια για τον προσδιορισμο πεπτιδιων και πρωτεϊνων βιολογικου ενδιαφεροντος | |
ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
ATE426168T1 (de) | Verwendung von asc als marker fur kolorektalkarzinome | |
ATE545867T1 (de) | I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom | |
PE20120592A1 (es) | Metodo con biomarcadores para el seguimiento de un tratamiento | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
ATE555385T1 (de) | N1,n12-diacetylspermin als tumormarker | |
WO2010000467A8 (en) | Asc as a marker for lung cancer | |
DE602007004570D1 (de) | Verwendung von Nogo-C bei der Beurteilung von Herzversagen | |
ATE353544T1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome | |
ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs | |
WO2010130839A4 (en) | Cybp as a marker of lung cancer | |
HUP0303890A2 (hu) | Differenciációs nukleinsavak és polipeptidek inhibitorának prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1831695 Country of ref document: EP |